ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1877

Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI

Walter Maksymowych1, Liron Caplan2, Atul Deodhar3, Soha Dolatabadi4, Mark Hwang5, Adam Carlson6, Kelly Steed7, Amanda Carapellucci8, Joel Paschke8 and Lianne Gensler9, 1University of Alberta, Edmonton, AB, Canada, 2Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, 3Oregon Health & Science University, Portland, OR, 4Soha Dolatabadi, MD, Los Angeles, CA, 5McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 6University of Virginia, Charlottesville, VA, 7James J. Peters VA Medical Center, Bronx, NY, 8CARE Arthritis, Edmonton, AB, Canada, 9University of California San Francisco, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), Diagnostic criteria, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Diagnosis of axial spondyloarthritis (axSpA) is challenging because of absent physical findings in early disease and the limited diagnostic performance of laboratory markers. Considerable reliance is placed on imaging of the sacroiliac joints (SIJ). We aimed to identify what might be the primary unmet educational needs of rheumatologists completing fellowship training within the past 6 years (post-F) by using clinical and imaging data from an inception cohort of consecutive patients presenting with undiagnosed back pain. We hypothesized that concordance between post-F rheumatologists and axSpA experts would increase after imaging data is reviewed following the clinical data.

Methods: The diagnosis of axSpA was compared between local site rheumatologists recruiting patients for the cohort, axSpA experts who reviewed the diagnostic ascertainments, and post-F rheumatologists who assessed clinical and imaging data from the multicenter Screening for Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis (SASPIC) Study. In this inception cohort, consecutive patients ≤45 years of age with ≥3 months undiagnosed back pain undergo routine diagnostic evaluation by a local SASPIC rheumatologist, including imaging of the SIJ, who then records a global evaluation of presence/absence of axial SpA. This is done at 3 consecutive stages: 1.After the clinical evaluation. 2.After the results of labs (HLA B27, CRP) and radiography. 3.After review of the local MRI report. In this exercise, 20 cases were selected from the SASPIC cohort with an equal distribution of axSpA and non-axSpA cases. Four experts in axSpA reviewed the clinical and imaging data in each eCRF in a sequential manner and provided their global diagnostic evaluations blinded to the assessments of local site rheumatologists for stages 1, 2, and 3 of these 20 cases. Subsequently, 4 post-F rheumatologists conducted the same exercise blinded to the assessments of the local site rheumatologist and experts in axSpA. Concordance (% agreement) between the assessors was analyzed.

Results: Diagnosis of axSpA by the local SASPIC rheumatologist was made in 90%, 65%, and 75% of cases after stages 1, 2, and 3, respectively. Majority diagnosis of axSpA by experts was made in 84.2% (16/19), 57.9% (11/19), and 63.2% (12/19), after stages 1,2, and 3, respectively. Majority diagnosis of axSpA by post-F rheumatologists was made in 94.4% (17/18), 100% (16/16), and 93.8% (15/16).  Concordance among experts and between experts and local SASPIC rheumatologists increased after review of imaging data. For post-F rheumatologists concordance with experts increased after review of imaging for 2 assessors and decreased for the other 2 assessors. For the latter, the primary reason for decrease in concordance with experts was false positive diagnosis of axSpA in 35% and 30% of the cases after review of the imaging.

Conclusion: A structured case-based and sequential evaluation of clinical and imaging data suggests a gap in the training of recently graduated rheumatologists, with over-interpretation of imaging leading to false positive diagnosis of axSpA. 


Disclosure: W. Maksymowych, CARE Arthritis Limited, 9, AbbVie, 2, 5, 8, Boehringer Ingelheim, 5, Celgene, 5, Eli Lilly, 5, Galapagos, 5, Janssen, 5, 8, Novartis, 2, 5, 8, Pfizer, 2, 5, 8, UCB, 2, 5, 8; L. Caplan, None; A. Deodhar, AbbVie, 2, 5, Eli Lilly, 2, 5, GlaxoSmithKline, 2, 5, Novartis, 2, 5, Janssen, 5, Pfizer, 2, 5, Boehringer Ingelheim, 5, UCB Pharma, 2, 5, Amgen Inc., 5, Celgene, 5, Galapagos, 5, Bristol-Myers Squibb, 2; S. Dolatabadi, None; M. Hwang, Novartis, 5, University of Texas Health Science Center at Houston (UTHealth) Center of Clinical and Translational Sciences KL2 program, 2; A. Carlson, None; K. Steed, None; A. Carapellucci, None; J. Paschke, None; L. Gensler, AbbVie, 5, GlaxoSmithKline, 5, Eli Lilly, 5, Novartis, 2, 5, Pfizer, 2, 5, UCB Pharma, 2, 5.

To cite this abstract in AMA style:

Maksymowych W, Caplan L, Deodhar A, Dolatabadi S, Hwang M, Carlson A, Steed K, Carapellucci A, Paschke J, Gensler L. Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/diagnosis-of-axial-spondyloarthritis-a-primary-unmet-educational-need-for-rheumatologists-is-interpretation-of-mri/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnosis-of-axial-spondyloarthritis-a-primary-unmet-educational-need-for-rheumatologists-is-interpretation-of-mri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology